Lurasidone

Details

Files

Generic Name:

Lurasidone

Project Status:

Complete

Therapeutic Area:

Schizophrenia

Manufacturer:

Sunovion Pharmaceuticals Inc.

Call for patient/clinician input open:

June 20, 2012

Brand Name:

Latuda

Project Line:

Reimbursement Review

Project Number:

SR0284-000

Call for patient/clinician input closed:

July 24, 2012

NOC Status at Filing:

Post NOC

Submission Type:

Initial

Indications:

schizophrenia

Recommendation Type:

Do not list

Final Recommendation:

January 23, 2013

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : July 3, 2012